Gilead disputes report that coronavirus drug trial flopped

Gilead Sciences Inc's experimental coronavirus drug failed its first randomized clinical trial, the Financial Times reported on Thursday, but the drugmaker said the results from the study in China was inconclusive as it was terminated early.